Cargando…
Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
Patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular disease (CVD). Unfortunately, several potential barriers exist for CVD risk management in diabetes, including the need for significant lifestyle changes, potential problems with hypoglycemia, weight gain, injectio...
Autores principales: | Hermansen, Kjeld, Mortensen, Lene Sundahl, Hermansen, Marie-Louise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515417/ https://www.ncbi.nlm.nih.gov/pubmed/18827907 |
Ejemplares similares
-
Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience
por: Hermansen, Kjeld, et al.
Publicado: (2015) -
Differential effects of dietary protein sources on postprandial low-grade inflammation after a single high fat meal in obese non-diabetic subjects
por: Holmer-Jensen, Jens, et al.
Publicado: (2011) -
The Dynamic Effects of Isosteviol on Insulin Secretion and Its Inability to Counteract the Impaired β-Cell Function during Gluco-, Lipo-, and Aminoacidotoxicity: Studies In Vitro
por: Gu, Wenqian, et al.
Publicado: (2018) -
Effects of antidiabetic agents on Alzheimer’s disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin
por: Ali, Shatw Khalid, et al.
Publicado: (2022) -
Pre-Meal Effect of Whey Proteins on Metabolic Parameters in Subjects with and without Type 2 Diabetes: A Randomized, Crossover Trial
por: Bjørnshave, Ann, et al.
Publicado: (2018)